【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Psoriasis: Condition overview
• Prevalence
• Economic burden of psoriasis
PART 06: Pipeline analysis
• Novel mechanisms targeted by pipeline candidates
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Market segmentation by type of molecule
• Global biologics market
• Small molecules
PART 09: Market segmentation by mechanism of action
• TNF inhibitors
• PDE4 inhibitors
• IL blockers
• Others
PART 10: Market segmentation by severity of disease
• Mild psoriasis
• Moderate psoriasis
• Severe psoriasis
PART 11: Market segmentation by ROA
• Oral
• Parenteral
PART 12: Geographical segmentation
• Systemic psoriasis therapeutics market in Americas
• Systemic psoriasis therapeutics market in US
• Systemic psoriasis therapeutics market in EMEA
• Systemic psoriasis therapeutics market in APAC
PART 13: Market drivers
• Dominance of market by biologics
• Increase in psoriatic patient pool due to new diagnostic procedures
• Recurrence of psoriasis
• Expected approval of late-stage pipeline molecules
PART 14: Impact of drivers
PART 15: Market challenges
• Physician’s reluctance to prescribe biosimilars
• Innovative blue LED device and magnetic therapy as potential therapeutics substitutes
• Unknown disease etiology
• Use of CAM and topical drugs to treat psoriasis
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Advent of biologics with novel MOA and cell-based strategies
• Emergence of next-generation systemic psoriatic therapies
• Preference for combination therapies
• Popularity of off-label systemic medications
PART 18: Vendor landscape
• Competitive scenario
• Upcoming vendors
• Key news
• AbbVie
• Johnson & Johnson
• Celgene
• Amgen
• Pfizer
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Economic burden of psoriasis
Exhibit 03: Annual treatment costs of psoriasis 2014 ($)
Exhibit 04: Global systemic psoriasis therapeutics market: Pipeline portfolio
Exhibit 05: Pipeline share of molecules in different stages of development 2015
Exhibit 06: Novel targets of pipeline candidates
Exhibit 07: Share of novel pipeline molecules based on their MOA 2015
Exhibit 08: Approvals and patent expiries of top selling biologics
Exhibit 09: Global systemic psoriasis therapeutics market 2015-2020 ($ billions)
Exhibit 10: Global systemic psoriasis therapeutics market snapshot: Developed and emerging markets 2015
Exhibit 11: A few patient assistance programs offered by various companies
Impact of drivers and challenges on the market
Exhibit 12: Impact of key customer segments on market 2015
Exhibit 13: Opportunities faced by psoriasis industry today
Exhibit 14: Five forces analysis
Exhibit 15: Global systemic psoriasis therapeutics market: Segmentation by type of molecule (2015-2020)
Exhibit 16: Global systemic psoriasis therapeutics market: Segmentation by type of molecule 2015
Exhibit 17: Competitive assessment of marketed and late-stage pipeline molecules
Exhibit 18: Global biologics market 2015-2020 ($ billions)
Exhibit 19: Opportunity analysis of global systemic psoriasis therapeutics market by type of molecule
Exhibit 20: Impact of biologics on various sectors
Exhibit 21: Global small molecules market 2015-2020 ($ millions)
Exhibit 22: Average percentage of patients receiving TNF inhibitors 2010 and 2015
Exhibit 23: Global systemic psoriasis therapeutics market segmentation by MOA 2015
Exhibit 24: Global systemic psoriasis therapeutics market segmentation by MOA 2020
Exhibit 25: Global systemic psoriasis therapeutics market segmentation by severity of disease 2015
Exhibit 26: Global systemic psoriasis therapeutics segmentation by ROA 2015
Exhibit 27: Global systemic psoriasis therapeutics market: Geographical outlook (2015-2020)
Exhibit 28: Global systemic psoriasis therapeutics market: Geography outlook 2015
Exhibit 29: Revenue/growth outlook in different countries/regions 2015
Exhibit 30: Systemic psoriasis therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 31: Systemic psoriasis therapeutics market in America by country 2015
Exhibit 32: Systemic psoriasis therapeutics market in US 2015-2020 ($ billions)
Exhibit 33: Systemic psoriasis therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 34: Systemic psoriasis therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 35: Global systemic psoriasis therapeutics market by geographical segmentation 2015
Exhibit 36: Global systemic psoriasis therapeutics market by geographical segmentation 2020
Exhibit 37: Global systemic psoriasis therapeutics market revenue by geography 2015-2020 ($ billions)
Exhibit 38: Biologicals approvals by US FDA
Exhibit 39: List of some pipeline molecules
Exhibit 40: Impact of drivers
Exhibit 41: Key reasons to prescribe biosimilars 2015
Exhibit 42: CAM and topical drugs for psoriasis
Exhibit 43: Usage of CAMs in US 2014
Exhibit 44: Impact of drivers and challenges
Exhibit 45: Psoriasis market: Impact assessment of top trends 2015
Exhibit 46: Market share of major vendors for global systemic psoriasis therapeutics market 2015
Exhibit 47: Competitive assessment of vendors
Exhibit 48: Key vendors: Geographical presence 2015
Exhibit 49: YoY sales comparison of top selling drugs 2013-2015 ($ billions)
Exhibit 50: Upcoming vendors
Exhibit 51: AbbVie: Product segmentation by revenue 2015
Exhibit 52: AbbVie: YoY revenue and growth rate of Humira 2013-2015 ($ billions)
Exhibit 53: AbbVie: YoY revenue and growth rate of Humira (in US) 2013-2015 ($ billions)
Exhibit 54: AbbVie: YoY revenue and growth rate of Humira (ROW) 2013-2015 ($ billions)
Exhibit 55: AbbVie: Metrics analysis
Exhibit 56: Johnson & Johnson: YoY growth rate and revenue of Remicade 2013-2015 ($ billions)
Exhibit 57: Johnson & Johnson: YoY growth rate and revenue of Remicade (in US) 2013-2015 ($ billions)
Exhibit 58: Johnson & Johnson: YoY growth rate and revenue of Remicade (ROW) 2013-2015 ($ billions)
Exhibit 59: Johnson & Johnson: YoY growth rate and revenue of Stelara 2013-2015 ($ billions)
Exhibit 60: Johnson & Johnson: YoY growth rate and revenue of Stelara (in US) 2013-2015 ($ millions)
Exhibit 61: Johnson & Johnson: YoY growth rate and revenue of Stelara (ROW) 2013-2015 ($ millions)
Exhibit 62: Johnson & Johnson: Metrics analysis
Exhibit 63: Celgene: YoY revenue comparison of Otezla 2014-2015 ($ millions)
Exhibit 64: Celgene: Metrics analysis
Exhibit 65: Amgen: YoY revenue and growth rate of Enbrel (in US and Canada) 2013-2015 ($ billions)
Exhibit 66: Amgen: YoY revenue and growth rate of Enbrel (in US) 2013-2015 ($ billions)
Exhibit 67: Amgen: YoY revenue and growth rate of Enbrel (in Canada) 2013-2015 ($ millions)
Exhibit 68: Amgen: Metrics analysis
Exhibit 69: Pfizer: YoY revenue and growth rate of Enbrel (outside US and Canada) 2013-2015 ($ billions)
Exhibit 70: Pfizer: Metrics analysis
【レポート販売概要】
■ タイトル：全身性乾癬治療薬の世界市場2016-2020■ 英文：Global Systemic Psoriasis Therapeutics Market 2016-2020
■ 発行日：2016年7月12日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9772
■ 調査対象地域：グローバル
- アロイリチン酸の世界市場Aleuritic acid (CAS 533-87-9) Market Research Report 2014 presents comprehensive data on aleuritic acid markets globally and regionally (Europe, Asia, North America etc.) The report includes aleuritic acid description, covers its application areas and related patterns. It overviews aleuritic acid market, names aleuritic acid producers and indicates its suppliers. Besides, the report provides aleur …
- 熱処理式空気ろ過の世界市場：熱酸化装置、再生熱酸化装置（RTO）、触媒酸化装置、再生触媒酸化装置（RCO）About Thermal Treatment Air Filtration Thermal treatment air filtration is a method of filtering exhaust gases generated by various industrial processes. The exhaust gases are heated to a very high temperature in the oxidizing chamber, thus breaking the bond between polluting compounds. The compounds then mix with the oxygen present in the chamber to form CO2 and H2O. It is suitable for removing h …
- 世界の溶接ロボット市場動向（2012-2016）TechNavio's analysts forecast the Global Welding Robots market to grow at a CAGR of 5.73 percent over the period 2012-2016. One of the key factors contributing to this market growth is need for faster time to market. The Global Welding Robots market has also been witnessing the increasing focus on providing end-to-end solutions. However, limited knowledge about welding robots’ functionalities coul …
- ヨーロッパのTall Oil, Whether or Not Refined市場The report provides a complete overview of the tall oil, whether or not refined market in EU countries in a comprehensive and easily accessed format. Market current state, historical figures and future development are in the report. Scope The report gives in-depth analysis of the European Union market for tall oil, whether or not refined with data for EU in total and by country Current statistics, …
- 自動車用アルミニウムの世界市場予測（～2026）：製品形態別（鋳造アルミニウム、圧延アルミニウム、押出アルミニウム）、用途別（伝動機構、車台・車体懸架装置、車体）、車両種類別（乗用車、小型商用車、重型商用車）、地域別“The automotive aluminum market is projected to grow at a CAGR of 8.8% from 2016 to 2026, in terms of value.” The automotive aluminum market is projected to reach USD 111.80 billion by 2026, at a CAGR of 8.8% from 2016 to 2026. Aluminum offers various performance benefits as it is light in weight and is more rigid as compared to steel, which makes it preferred material for automotive manufacturers …
- 細胞診断の世界市場：技術別（免疫組織化学、インサイツハイブリダイゼーション、デジタル・解剖病理学）、用途別、最終用途別、セグメント予測The global tissue diagnostics market size is expected to reach USD 6.03 billion by 2025 at a 6.6% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Major developments pertaining to consolidation, automation, and efficiency analysis to streamline tissue-based disease screening protocols and cashflows have driven this market. Furthermore, collaborations for deve …
- 世界の水晶発振器市場：Global Crystal Oscillator Market 2014-2018TechNavio forecasts The Global Crystal Oscillator Market 2014-2018 with a CAGR of 5.4 percent for the period 2013-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors to …
- 抗肥満薬の世界市場：末梢作用型抗肥満薬、中枢作用型抗肥満薬About Obesity Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure. TechNavio's analysts forecast the Global Anti-obesity Drugs market to grow at a CAGR of 39.45 percent o …
- 半導体マイクロ部品の世界市場2017-2021：マイクロプロセッサ、マイクロコントローラ、DSPAbout Semiconductor Micro Components Semiconductor micro components are an important part of all the electronic devices. Their adoption is directly proportional to the number of electronic devices being sold. The increased popularity of IoT has led to the need of powerful electronics, which in turn has led to the demand for powerful processors. Local processing capability is most often provided by …
- 世界のSoftware-Defined Network（SDN）市場展望（～2018）The software-defined networking (SDN) is a burgeoning industry and it exhibits immense potential for growth in coming years. Factors such as rising need for mobility across enterprises, an efficient network of infrastructure and declining cost of network maintenance & operations through SDN deployment are driving the growth of the SDN market. Considering these, the market is slated to grow at a CA …
- Rex Energy Corporation：石油・ガスバリューチェーン分析レポート2013Rex Energy Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Rex Energy Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Rex Energy Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
- 溶射コーティングの世界市場予測（～2023年）“The thermal spray coatings market is projected to grow at a CAGR of 6.7% between 2018 and 2023.”The thermal spray coatings market is estimated to be USD 9.9 billion in 2018 and is projected to reach USD 13.7 billion by 2023, at a CAGR of 6.7% from 2018 to 2023. The growth of the aerospace, automotive, and healthcare industries is driving the demand for thermal spray coatings. “The ceramics segmen …
- 1,5-ジアミノペンタンの世界市場1,5-Diaminopentane (CAS 462-94-2) Market Research Report 2013 presents comprehensive data on 1,5-diaminopentane markets globally and regionally (Europe, Asia, North America etc.) The 1,5-Diaminopentane (CAS 462-94-2) Market Research Report 2013 includes 1,5-diaminopentane description, covers its application areas and related patterns. It overviews 1,5-diaminopentane market, names 1,5-diaminopentan …
- 米州のスマートマシン市場：エキスパートシステム、自律ロボット、デジタルアシスタントAbout the Smart Machines Market in the Americas Smart machines have cognitive computing ability, and use artificial intelligence (AI) and machine learning algorithms to sense, learn, reason, and interact with humans. They offer desired output and solve problems accurately and precisely. The rising concept of Industry 4.0 that include automation, IoT, cloud computing, and smart machines in the auto …
- 肝腎症候群(Hepatorenal Syndrome)：世界の治験レビュー（2015年上半期版）Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Hepatorenal Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatorenal Syndrome. It includes an overview of the trial numbers and their r …
